A combination DNA vaccine encoding nucleoside hydrolase 36 and glycoproteine 63 protects female but not male hamsters against Leishmania mexicana
Parasite, 16 3 (2009) 227-230
Published online: 2009-09-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
NAMS task force report on vector borne diseases
Nirmal Kumar Ganguly, Anup R Anvikar, Duane J Gubler, Kamini Mandis, Mary Cameron, A.C. Dhariwal, Navin Khanna, Suman Rijal, AP Dash, Neena Valecha, Neeraj Dhingra, Pradeep Das, Ashwani Kumar, Sushanta Kumar Gosh, Ujjwal Neogi, Rashmi Rana, Ekta Gupta, Amandeep Singh, Praveen Kumar Bharti and Ritesh RanjhaAnnals of the National Academy of Medical Sciences (India) 61 394 (2025)
https://doi.org/10.25259/ANAMS_TFR_15_2024
Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges
Eduardo A. F. Coelho and Myron ChristodoulidesVaccines for Neglected Pathogens: Strategies, Achievements and Challenges 281 (2023)
https://doi.org/10.1007/978-3-031-24355-4_13
3M‐052 as an adjuvant for a PLGA microparticle‐based Leishmania donovani recombinant protein vaccine
Qian Wang, Meagan A. Barry, Christopher A. Seid, Elissa M. Hudspeth, C. Patrick McAtee and Michael J. HeffernanJournal of Biomedical Materials Research Part B: Applied Biomaterials 106 (4) 1587 (2018)
https://doi.org/10.1002/jbm.b.33965
Folate Functionalized PLGA Nanoparticles Loaded with Plasmid pVAX1-NH36: Mathematical Analysis of Release
Cindy Gutiérrez-Valenzuela, Patricia Guerrero-Germán, Armando Tejeda-Mansir, Reynaldo Esquivel, Roberto Guzmán-Z and Armando Lucero-AcuñaApplied Sciences 6 (12) 364 (2016)
https://doi.org/10.3390/app6120364
Expression and purification of an engineered, yeast-expressedLeishmania donovaninucleoside hydrolase with immunogenic properties
Elissa M. Hudspeth, Qian Wang, Christopher A. Seid, et al.Human Vaccines & Immunotherapeutics 1 (2016)
https://doi.org/10.1080/21645515.2016.1139254
The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas
Kristina M. Bacon, Peter J. Hotez, Stephanie D. Kruchten, et al.Vaccine 31 (3) 480 (2013)
https://doi.org/10.1016/j.vaccine.2012.11.032
Texas and Mexico: Sharing a Legacy of Poverty and Neglected Tropical Diseases
Peter J. Hotez, Maria Elena Bottazzi, Eric Dumonteil, et al.PLoS Neglected Tropical Diseases 6 (3) e1497 (2012)
https://doi.org/10.1371/journal.pntd.0001497
Adaptive Immunity against Leishmania Nucleoside Hydrolase Maps Its C-Terminal Domain as the Target of the CD4+ T Cell–Driven Protective Response
Dirlei Nico, Carla Claser, Gulnara P. Borja-Cabrera, et al.PLoS Neglected Tropical Diseases 4 (11) e866 (2010)
https://doi.org/10.1371/journal.pntd.0000866